Advate in haemophilia A outcome Database

Hamostaseologie

Volumn 30, Issue SUPPL.1, 2010, Pages 23-25

  Oldenburg, J ^a   Kurnik, K ^b   Huth Kuhne A ^c   Zimmermann, R ^c   Abraham, I ^d   Klamroth, R ^e  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c Kurpfalzkrankenhaus Heidelberg ^*  (Germany)

^d Fa Baxter Deutschland GmbH   (Germany)

^e Vivantes Klinikum Friedrichshain   (Germany)

Author keywords

Advate; AHEAD; Haemophilia; Outcome

Indexed keywords

BLOOD CLOTTING FACTOR 8;

ARTICLE; CLINICAL TRIAL; DATA BASE; HEMOPHILIA A; HUMAN; METABOLISM; MULTICENTER STUDY; PATIENT SELECTION; PROSPECTIVE STUDY; TREATMENT OUTCOME;

DATABASES AS TOPIC; FACTOR VIII; HEMOPHILIA A; HUMANS; PATIENT SELECTION; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79952111905     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Aledort LM, Haschmeyer RH, Petterson H. A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. J Intern Med 1994; 236: 391-399.
2. Pettersson H, Ahlberg A, Nilsson IM. A radiologic classification of haemophilic arthropathy. Clin Orthop 1980; 149: 153-159.
3. Brackmann HH, Eickhoff HJ, Oldenburg J, Hammerstein U. Long-term therapy and on-demand treatment of children and adolescents with severe haemophilia A: 12 years of experience. Haemostasis 1992; 22: 251-258.
4. Epstein J, Li-McLeod JM, Yarlas AS. The impact of target joint development on health related quality of life for adult hemophilia A patients: results from the PASS study. Poster at the XXII Congress of the International Society on Thrombosis and Haemostasis. July 2009, Boston (MA), USA.
5. Lassila R, Rothschild C, De Moerloose P et al. Reommendations for postmarketing surveillance studies in haemophilia and other bleeding disorders. Haemophilia 2005; 11: 353-359.